You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上市新规三周年 港交所(00388.HK)指新经济上市公司重塑港资本市场
阿思达克 04-29 14:59
港交所(00388.HK)推行上市改革三周年,包括允许未有收入的生物科技公司、采用不同投票权架构的新经济公司及合资格的海外上市公司来港第二上市。

港交所表示,过去三年新股融资额中有61%来自新经济公司,并成为亚洲最大及全球第二大的生物科技融资中心,共有31家未有收入的生物科技公司於香港上市,总融资额达821亿元。另有13家第二上市的中概股,总融资额达2,858亿元。

港交所代理集团行政总裁戴志坚表示,上市改革让香港资本市场焕然一新。港交所已成为国际领先的新经济公司融资市场和全球第二大生物科技融资中心,将在确保市场质素的前提下,继续提升香港市场的吸引力与竞争力,进一步巩固香港作为国际金融中心的地位。

港交所指,自上市新规生效後,来自新经济公司的新股融资额比例不断上升,由2018年和2019年的49%攀升至2020年的64%。总市值为14.45万亿元,占香港市场总市值的27%。而对股票市场成交金额的贡献,更从2018年的仅1%增长至去年的21%。

另外,今年新经济公司新股融资需求持续强劲,首季有18家新经济公司上市,融资额1,292亿元,占香港市场新股融资额的95%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account